ストックスクリーナーアプリを入手
3.97
0.04%
-0.02
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
Number of shareholders of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKTW - TradingView
Director at Rocket Pharmaceuticals (RCKT) receives RSUs and stock options - Stock Titan
Rocket Pharmaceuticals (RCKT) director Southwell awarded RSUs and 64,860-share option - Stock Titan
RCKT Stock Jumps Over 10% Premarket: FDA Approves Its First Gene Therapy For Rare Childhood Immune Disease - Stocktwits
Rocket Pharmaceuticals, Inc. Warrant 2023- on Rocket Pharmctc Financial Disclosures & SEC Filings - TradingView
RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits
Rocket Pharmaceuticals Appoints Joseph Manhede as Principal Accounting Officer – SEC 8-K Filing June 2026 - Minichart
Rocket Pharmaceuticals (NASDAQ: RCKT) appoints new Principal Accounting Officer - Stock Titan
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) added to Russell Microcap Value Benchmark Index - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell 3000E Index - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell Microcap Index - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Join Class Action to Recover Losses from Rocket Pharmaceuticals - The National Law Review
RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action - The National Law Review
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi - The National Law Review
Investors Urged to Contact Levi & Korsinsky for Information Befor - The National Law Review
Rocket Pharmaceuticals, Inc. (RCKT) LawsuitInvestors Urged to Contact Levi & Korsinsky Before August 11, 2025 - The National Law Review
TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits
Price to earnings forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView
Price to sales forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView
Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView
Rocket Pharma updates cash position after selling priority review voucher - MSN
Price to sales forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Rocket Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:RCKT) - TradingView
Rocket Pharmaceuticals, Inc. Actuals & Estimates (HAM:9IP1) - TradingView
Rocket Pharmaceuticals, Inc. Actuals & Estimates (TRADEGATE:9IP1) - TradingView
Price to sales forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
RCKT Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone? - Insider Monkey
Price to book forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Price to earnings forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Enterprise value to EBIT forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Rocket Pharmaceuticals Inc (RCKTW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Price to book forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
Rocket Pharmaceuticals Inc (RCKT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Institutional Confidence - TradingKey
ROCKET PHARMACEUTICALS INC (RCKT) Stock Chart - ChartMill
Rocket Pharmaceuticals analyst consensus stays supportive, shares trade near recent lows - AD HOC NEWS
Rocket Pharmaceuticals Inc (RCKT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Rocket Pharmaceuticals Inc (RCKTW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Can Rocket Pharmaceuticals (NASDAQ:RCKT) Afford To Invest In Growth? - Moomoo
Rocket Pharmaceuticals Inc (RCKT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rocket Pharmaceuticals Inc (RCKTW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rocket Pharmaceuticals Inc (RCKTW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rocket Pharmaceuticals Inc (RCKTW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rocket Pharmaceuticals Inc (RCKTW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc (RCKTW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rocket Pharmaceuticals Inc (RCKTW) Institutional Confidence - TradingKey
Rocket Pharmaceuticals Delivers Bold Moves Amid Volatile Market - timothysykes.com
1.16%
0.48%
大文字化:
|
ボリューム (24 時間):